Paradise regained: insights into coronary heart disease prevention from recent clinical trials and basic research

Area of Science:

• Cardiology
• Preventive Medicine
• Atherosclerosis Research

Background:

• Uncertainties in lipid lowering for coronary heart disease (CHD) prevention are diminishing.
• Newer findings necessitate a re-evaluation of clinical approaches to CHD prevention.
• Understanding of arterial pathology has advanced, influencing lipid management strategies.

Purpose of the Study:

• To review recent evidence on lipid lowering in coronary heart disease (CHD) prevention.
• To examine the scope for a revised clinical approach based on new findings.
• To explore the relationship between angiographic and clinical outcomes in CHD.

Main Methods:

• Review of lipid-lowering trials with clinical and angiographic end-points.
• Analysis of meta-analyses from relevant clinical trials.
• Examination of variables predicting coronary artery disease (CAD) progression, including nutrient intake.

Main Results:

• Lipid lowering's role in CHD prevention is becoming clearer.
• A strong correlation exists between coronary angiographic findings and clinical outcomes.
• Clinical and biochemical risk assessments can be augmented by advanced imaging techniques.

Conclusions:

• Management of hyperlipidemia should align treatment goals with patient cardiovascular risk.
• Angiographic and non-invasive methods can enhance risk assessment by identifying high-risk atherosclerotic lesions.
• Revised clinical strategies for CHD prevention are supported by recent evidence.